548 days ago
Hurst has not stuck the ball in the back of the net yet but the crowd of bears are on the pitch clutching bottles of ouzo and is that a Fat Lady I see among them? Surely this disgrace from the IPO class of 2021 is doomed after the latest news? You cannot say that I did not, on numerous occasions, warn you all
1075 days ago
With a hat tip to MB, I note that at 4:30 PM and 4:31 PM Friday, Futura Medical (FUM) announced that there was a placing and retail offer at 40p per share. Unfortunately, somebody at Nomad Liberum had forgotten that the market doesn’t actually close until 4:35 PM after the closing auction (which has been the case since 1997).
1698 days ago
In today’s podcast I start with a couple of reflections on the joys of modern life involving Andrew Monk of VSA, cannabis and the tossers at Barclays Bank (BARC). I look at Burford (BUR), Falanx (FLX), IQE (IQE), Xaar (XAR), Providence Resources (PVR) and Lansdowne Oil & Gas (LOGP). I forgot to mention Restaurant Group (RTN) but Chris “Three Brains” Bailey, again, covers it very well HERE and he is right. It is a slam dunk sell. Lucian Miers reckons it might just be a zero.
2910 days ago
Okay the research note claiming that shares in Sirius Minerals (SXX) will zoom from 18p to 40p is made by its own house broker Liberum. On that basis it is - like all house broker buy notes - to be taken with many pinches of salt. But just to annoy my pal Lucian Miers who is short and to show we are happy to offer a variety of views. To be clear, I personally have no view.
3704 days ago
Twenty four hours ago I asked a number of questions of Phorm (PHRM) and its ex Nomad Liberum regarding the Chinese investment promised but not delivered in 2012. News of this “investment” caused the stock to rocket allowing a placing at 125p (the shares are now 11p) but it never happened.
Needless to say neither Phorm nor Liberum seem terribly keen to answer my questions. Perhaps they will be more forthcoming with others.
3705 days ago
Poor Phorm (PHRM) …it will have run out of cash within six weeks and so unless it can get away yet another fund raise it will be toast by Easter. But before we look forward to that, I have a number of questions for AIM Cessoit listed Phorm and its former Nomad Liberum about events back in 2012.
On 1st June 2012 Phorm announced that it had managed to persuade an investor to buy 20% of it’s (yet to start up) Chinese subsidiary for £20 million. The implication was that Phorm’s retained stake was worth £80 million and as a read through its operations outside China would be worth an awful lot.
The statement reads.
